International News

Ruling confirms Germany’s designation that CBD is a ‘novel food’

A court case confirmed that German authorities consider CBD products either a prescription medicine or novel food. The ruling followed the direction of the European Union (EU), which has ruled that the cannabinoid and products containing cannabidiol can’t be yet be sold without additional safety research. The novel foods distinction is given to products if […]

Read More

Losses narrow for GW Pharmaceuticals on dramatic revenue increase

A strong uptick in doctor prescriptions and coverage from health insurers is being credited for solid quarterly revenues for GW Pharmaceuticals. The London-based firm that makes cannabis-derived CBD medicines reported revenue of $91 million for the third quarter ended Sept. 30, up more than 3,500% from the same period a year ago. Despite the revenue […]

Read More

Border seizures of hemp continue despite legalization, lawsuit, importer says

This story has been updated with a section discussing new import/export rules on live hemp plants. A California CBD manufacturer challenging the hemp policies of the U.S. Customs and Border Protection agency says hemp seizures are still taking place despite nationwide legalization and a federal judge’s assurance that border seizures of legal hemp are a thing […]

Read More

Canadian cannabis company planning to grow 17,000 acres of hemp in China

A Toronto marijuana producer is making plans to grow hemp in China to make CBD and other hemp products. Pure Global Cannabis announced Tuesday it signed an agreement to grow roughly 17,000 acres of hemp in the Yunnan province. Pure Global Cannabis says it will operate its China hemp operation with another company, KMT-Hansa Corp. […]

Read More

CBD drug Epidiolex approved for use in Europe, GW Pharmaceuticals says

The only federally approved CBD product in the U.S. has been OK’d by European authorities for use there. The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In June 2018, the U.S. Food and Drug Administration approved Epidiolex for the treatment of seizures associated with two rare kinds […]

Read More

London cannabis investment fund acquires UK CBD manufacturer

A London cannabis investment firm has acquired a CBD manufacturer to launch its foray into European markets. World High Life will buy Love Hemp, which makes CBD topicals and edibles, for $11.23 million, the company announced Monday. Love Hemp products are distributed in convenience stores and drugstores. World High Life said the acquisition would give […]

Read More

Ecuador considers hemp changes amid broader cannabis review

Ecuador may change its laws around hemp as part of a broader overhaul of how the South American country treats medical cannabis. Last week, Ecuador’s Congress approved a major reform of the Organic Integral Criminal Code. Ecuador is one of the few South American countries that still has not legalized hemp nor medical cannabis. If given […]

Read More